PolyPeptide Group Future Growth
Future criteria checks 4/6
PolyPeptide Group is forecast to grow earnings and revenue by 69.3% and 11% per annum respectively. EPS is expected to grow by 71.7% per annum. Return on equity is forecast to be 8.8% in 3 years.
Key information
69.3%
Earnings growth rate
71.7%
EPS growth rate
| Life Sciences earnings growth | 19.6% |
| Revenue growth rate | 11.0% |
| Future return on equity | 8.8% |
| Analyst coverage | Good |
| Last updated | 01 Jul 2024 |
Recent future growth updates
Recent updates
Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?
Jun 19
Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce
Mar 14PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price
Mar 13PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 18Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings
Mar 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 481 | 33 | -14 | 49 | 5 |
| 12/31/2025 | 409 | 12 | -20 | 44 | 6 |
| 12/31/2024 | 349 | -12 | -41 | 20 | 6 |
| 12/31/2023 | 320 | -51 | -20 | 36 | N/A |
| 9/30/2023 | 300 | -44 | -62 | 1 | N/A |
| 6/30/2023 | 279 | -37 | -104 | -35 | N/A |
| 3/31/2023 | 280 | -14 | -89 | -15 | N/A |
| 12/31/2022 | 281 | 8 | -73 | 5 | N/A |
| 9/30/2022 | 281 | 20 | -74 | 7 | N/A |
| 6/30/2022 | 281 | 33 | -75 | 9 | N/A |
| 3/31/2022 | 281 | 40 | -48 | 33 | N/A |
| 12/31/2021 | 282 | 47 | -20 | 57 | N/A |
| 9/30/2021 | 277 | 48 | -4 | 67 | N/A |
| 6/30/2021 | 271 | 48 | 13 | 77 | N/A |
| 3/31/2021 | 248 | 40 | 10 | 63 | N/A |
| 12/31/2020 | 224 | 31 | 6 | 49 | N/A |
| 12/31/2019 | 203 | 26 | 36 | 56 | N/A |
| 12/31/2018 | 181 | 24 | 5 | 23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PPGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: PPGN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PPGN is expected to become profitable in the next 3 years.
Revenue vs Market: PPGN's revenue (11% per year) is forecast to grow faster than the Swiss market (4.4% per year).
High Growth Revenue: PPGN's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PPGN's Return on Equity is forecast to be low in 3 years time (8.8%).